Serotonergic and noradrenergic function in depression: clinical correlates.

Abstract:

:The present study was conducted in order to investigate the relationships between central noradrenergic (NA) and serotonergic (5-HT) function and clinical characteristics of a major depressive episode according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. We measured growth hormone response (ΔGH) to clonidine (CLO) (an α2 NA agonist), as an index of central NA function, and prolactin response (APRL) to d-fenfluramine (d-FEN) (a specific 5-HT releaser/uptake inhibitor), as an index of central 5-HT function, in 53 medication-free depressed inpatients. On the basis of their CLO and d-FEN test responses, patients were classified into 4 groups. Group 1 (blunted ΔPRL(d-FEN) alone [11 %]) was characterized by a recent violent suicide attempt, a high degree of medical damage, and mild anxiety. Group 2 (blunted ΔGH(CLO) alone [32%]) was characterized by an absence of a history of suicide attempt and by severe anxiety. Group 3 (combination of blunted ΔGH(CLO) and APRL(d-FEN) [18%]) was characterized by a history of suicide attempts, total duration of the illness of over W years, age over 40 years, and more than 3 previous hospitalizations. Group 4 (no abnormality [39%]) had no specific clinical profile. These results suggest that, in depression, specific psychopathological features may be linked to 5-HT and/or NA dysfunction. However, our results also suggest that NA and/or 5-HT dysfunction are less likely to be the primary cause of mood disorders but are more indicative of failure of compensatory mechanisms involved in affective homeostatic processes.

authors

Duval F,Mokrani MC,Bailey P,Corrêa H,Crocq MA,Son Diep T,Macher JP

subject

Has Abstract

pub_date

2000-09-01 00:00:00

pages

299-308

issue

3

eissn

1294-8322

issn

1958-5969

journal_volume

2

pub_type

杂志文章
  • Partial remission, residual symptoms, and relapse in depression.

    abstract::Partial remission from depression, with residual symptoms, is an important problem in depression. This paper reviews the frequency and features of this outcome, and its association with relapse. Residual symptoms occur in many depressed patients after acute treatment. They span the typical symptoms of depression, exce...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Paykel ES

    更新日期:2008-01-01 00:00:00

  • Experimental models of stress.

    abstract::Illustrating the complexity of the stress response and its multifaceted manifestations is the leading idea of this overview of experimental paradigms used for stress induction in laboratory animals. The description of key features of models based on naturalistic stressors, pharmacological challenges, and genomic manip...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Patchev VK,Patchev AV

    更新日期:2006-01-01 00:00:00

  • The role of circadian clock genes in mental disorders.

    abstract::The study of molecular clock mechanisms in psychiatric disorders is gaining significant interest due to data suggesting that a misalignment between the endogenous circadian system and the sleep-wake cycle might contribute to the clinical status of patients suffering from a variety of psychiatric disorders. Sleep distu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Lamont EW,Legault-Coutu D,Cermakian N,Boivin DB

    更新日期:2007-01-01 00:00:00

  • Expression profiling of drug response--from genes to pathways.

    abstract::Understanding individual response to a drug-what determines its efficacy and tolerability-is the major bottleneck in current drug development and clinical trials. Intracellular response and metabolism, for example through cytochrome P-450 enzymes, may either enhance or decrease the effect of different drugs, dependent...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Herwig R,Lehrach H

    更新日期:2006-01-01 00:00:00

  • Lighting a path: genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders.

    abstract::In this review, we outline critical molecular processes that have been implicated by discovery of genetic mutations in autism. These mechanisms need to be mapped onto the neurodevelopment step(s) gone awry that may be associated with cause in autism. Molecular mechanisms include: (i) regulation of gene expression; (ii...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Pescosolido MF,Yang U,Sabbagh M,Morrow EM

    更新日期:2012-09-01 00:00:00

  • Depression and associated physical diseases and symptoms.

    abstract::Depression can occur in association with virtually all the other psychiatric and physical diagnoses. Physical illness increases the risk of developing severe depressive illness. There are two broadly different mechanisms. The most obvious has a psychological or cognitive mechanism. Thus, the illness may provide the li...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Goodwin GM

    更新日期:2006-01-01 00:00:00

  • The development concept of "endogenous psychoses".

    abstract::Several structural deviances in the brain in "endogenous psychoses" have been described over the last decades. The enlargement of the lateral ventricles and the subtle structural deficits in temporobasal and orbital frontal structures (hypofrontality) are reasonably well established in the majority of schizophrenic pa...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beckmann H,Jakob H,Senitz D

    更新日期:2006-01-01 00:00:00

  • Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism.

    abstract::Alcohol dependence is a frequent, chronic, relapsing, and incurable disease with enormous societal costs. Thus, alcoholism therapy and research into its outcome are of major importance for public health. The present article will: (i) give a brief overview of the epidemiology, pathogenesis, and treatment outcomes of al...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 临床试验,杂志文章

    doi:

    authors: Krampe H,Stawicki S,Hoehe MR,Ehrenreich H

    更新日期:2007-01-01 00:00:00

  • SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence.

    abstract::Caffeine is not considered addictive, and in animals it does not trigger metabolic increases or dopamine release in brain areas involved in reinforcement and reward. Our objective was to measure caffeine effects on cerebral perfusion in humans using single photon emission computed tomography with a specific focus on a...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Nehlig A,Armspach JP,Namer IJ

    更新日期:2010-01-01 00:00:00

  • Omics approaches to individual variation: modeling networks and the virtual patient.

    abstract::Every human is unique. We differ in our genomes, environment, behavior, disease history, and past and current medical treatment-a complex catalog of differences that often leads to variations in the way each of us responds to a particular therapy. We argue here that true personalization of drug therapies will rely on ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Lehrach H

    更新日期:2016-09-01 00:00:00

  • The impact of the digital revolution 
on human brain and behavior: where 
do we stand?
.

    abstract::This overview will outline the current results of neuroscience research on the possible effects of digital media use on the human brain, cognition, and behavior. This is of importance due to the significant amount of time that individuals spend using digital media. Despite several positive aspects of digital media, wh...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:10.31887/DCNS.2020.22.2/mkorte

    authors: Korte M

    更新日期:2020-06-01 00:00:00

  • Personalized medicine in psychiatry: ethical challenges and opportunities.

    abstract::Pharmacogenomic developments hold promise for personalized medicine in psychiatry with adjusted therapeutic doses, predictable responses, reduced adverse drug reactions, early diagnosis, and personal health planning. The prospects are exciting, but at the same time, these new techniques stand faced with important scie...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Evers K

    更新日期:2009-01-01 00:00:00

  • Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications.

    abstract::Major depressive disorder (MDD) is a major public health concern. Despite tremendous advances, the pathogenic mechanisms associated with MDD are still unclear. Moreover, a significant number of MDD subjects do not respond to the currently available medication. MicroRNAs (miRNAs) are a class of small noncoding RNAs tha...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Dwivedi Y

    更新日期:2014-03-01 00:00:00

  • Depression and end-of-life care for patients with cancer.

    abstract::Patients with cancer and depression experience more physical symptoms, have poorer quality of life, and are more likely to have suicidal thoughts or a desire for hastened death than are cancer patients who are not depressed. Despite the ubiquity of depressive symptoms in cancer patients at the end of life, critical qu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Rosenstein DL

    更新日期:2011-01-01 00:00:00

  • Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.

    abstract::There is mounting evidence that recurrent mood disorders - once considered "good prognosis diseases"- are, in fact, often very severe and life-threatening illnesses. Furthermore, although mood disorders have traditionally been conceptualized as neurochemical disorders, there is now evidence from a variety of sources d...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Quiroz JA,Manji HK

    更新日期:2002-03-01 00:00:00

  • New findings in the genetics of major psychoses.

    abstract::Schizophrenia and bipolar disorder have a largely unknown pathophysiology and etiology, but they are highly heritable. Although linkage and association studies have identified a series of chromosomal regions likely to contain susceptibility genes, progress in identifying causative genes has been largely disappointing....

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Nöthen MM,Nieratschker V,Cichon S,Rietschel M

    更新日期:2010-01-01 00:00:00

  • Depression in late life: psychiatric-medical comorbidity.

    abstract::The links between late-life depression and the medical comorbidities that are often associated with it can be divided into two paths. The path from medical illness to depression reflects general mechanisms related to stress, disability, and loss, as well as more specific physiological mechanisms, including those relat...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Katz IR

    更新日期:1999-09-01 00:00:00

  • Epilepsy research: a window onto function to and dysfunction of the human brain.

    abstract::As one of the most common neurological disorders, epilepsy has devastating behavioral, social, and occupational consequences and is associated with accumulating brain damage and neurological deficits. Epilepsy comprises a large number of syndromes, which vary greatly with respect to their etiology and clinical feature...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beck H,Elger CE

    更新日期:2008-01-01 00:00:00

  • Hypersomnia.

    abstract::Hypersomnia, a complaint of excessive daytime sleep or sleepiness, affects 4% to 6% of the population, with an impact on the everyday life of the patient Methodological tools to explore sleep and wakefulness (interview, questionnaires, sleep diary, polysomnography, Multiple Sleep Latency Test, Maintenance of Wakefulne...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Dauvilliers Y,Buguet A

    更新日期:2005-01-01 00:00:00

  • Ethology and the biological correlates of mood.

    abstract::The insights of ethology-the science of animal behavior from a biological and psychological point of view-were incorporated in the 1950s by the British developmental psychiatrist, John Bowlby, into his attachment theory, which argued that a secure affective base in infancy was critical to the normal development of per...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Cyrulnik B

    更新日期:2005-01-01 00:00:00

  • Ethical and public policy challenges for pharmacogenomics.

    abstract::It is timely to consider the ethical and social questions raised by progress in pharmacogenomics, based on the current importance of pharmacogenomics for avoidance of predictable side effects of drugs, and for correct choice of medications in certain cancers. It has been proposed that the entire population be genotype...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Gershon ES,Alliey-Rodriguez N,Grennan K

    更新日期:2014-12-01 00:00:00

  • Epigenetic signaling in psychiatric disorders: stress and depression.

    abstract::Psychiatric disorders are complex multifactorial disorders involving chronic alterations in neural circuit structure and function. While genetic factors play a role in the etiology of disorders such as depression, addiction, and schizophrenia, relatively high rates of discordance among identical twins clearly point to...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Bagot RC,Labonté B,Peña CJ,Nestler EJ

    更新日期:2014-09-01 00:00:00

  • Current perspectives in the management of treatment-resistant depression.

    abstract::Depressive disorders are a leading cause of disability worldwide and greatly impact morbidity, health care utilization, and medical costs. Major depression that does not resolve with adequate antidepressant treatment is termed treatment-resistant depression (TRD), There is no universally accepted definition of TRD and...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Parikh RM,Lebowitz BD

    更新日期:2004-03-01 00:00:00

  • DNA methylation and demethylation as targets for antipsychotic therapy.

    abstract::Schizophrenia (SZ) and bipolar disorder (BPD) patients show a downregulation of GAD67, reelin (RELN), brain-derived neurotrophic factor (BDNF), and other genes expressed in telencephalic GABAergic and glutamatergic neurons. This downregulation is associated with the enrichment of 5-methylcytosine and 5-hydroxymethylcy...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Guidotti A,Grayson DR

    更新日期:2014-09-01 00:00:00

  • Childhood predictors of states of anxiety.

    abstract::Development of the characteristics of social phobia often requires a diathesis in the form of a temperamental bias. A behavioral profile marked by vigorous motor activity and crying to unfamiliar stimuli at 4 months of age - called high reactivity- is characteristic of about 20% of healthy, Caucasian infants. This pat...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Kagan J

    更新日期:2002-09-01 00:00:00

  • The relationship between borderline personality disorder and bipolar disorder.

    abstract::It is clinically important to recognize both bipolar disorder and borderline personality disorder (BPD) in patients seeking treatment for depression, and it is important to distinguish between the two. Research considering whether BPD should be considered part of a bipolar spectrum reaches differing conclusions. We re...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Zimmerman M,Morgan TA

    更新日期:2013-06-01 00:00:00

  • Research on serotonin and suicidal behavior: neuroendocrine and molecular approaches.

    abstract::We carried out two studies to test the hypothesis that altered central serotonergic function, as assessed by lower prolactin (PRL) response to fenfluramine (D-FEN), is more closely associated with suicidal behavior than a particular psychiatric diagnosis. A D-FEN test was performed in 85 major depressed inpatients, 33...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Corrêa H,Romano-Silva MA,Duval F,Campi-Azevedo AC,Lima V,Macher JP

    更新日期:2002-12-01 00:00:00

  • Opposite effects of stressful experience on memory formation in males versus females.

    abstract::It has become increasingly clear that males and females differ even more dramatically than we previously thought. Not only do they exhibit differing responses to stress and environmental experience, but they can also respond in opposite directions. In rats, it has been shown that exposure to an acute stressful event c...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Shors TJ

    更新日期:2002-06-01 00:00:00

  • Autism and talent: the cognitive and neural basis of systemizing.

    abstract::In 2003, we proposed the hypersystemizing theory of autism. The theory proposes that the human mind possesses a systemizing mechanism (SM) that helps identify lawful regularities (often causal) that govern the input-operation-output workings of a system. The SM can be tuned to different levels, from low to high, with ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Baron-Cohen S,Lombardo MV

    更新日期:2017-12-01 00:00:00

  • Patient-reported outcomes in post-traumatic stress disorder. Part II: focus on pharmacological treatment.

    abstract::Post-traumatic stress disorder (PTSD) may be associated with long-lasting psychological suffering, distressing psychosocial disability, markedly reduced health-related quality of life, and increased morbidity and mortality in a subgroup of individuals in the aftermath of serious traumatic events. Both etiopathogenesis...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Kapfhammer HP

    更新日期:2014-06-01 00:00:00